ADORA2A and autoimmune disease: Numerous preclinical studies using A2AR agonists and antagonists, A2AR knockout and chimeric mice showed the therapeutic potential of A2AR agonists for the treatment of ischemia-reperfusion injury and autoimmune diseases [210].